Sinil Pharmaceutical Co., Ltd.

KOSDAQ:A012790 Stock Report

Market Cap: ₩79.3b

Sinil Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A012790?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme6,5630.0577%
Institutions114,6011.01%
Individual Insiders4,659,20541%
General Public6,595,90258%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 42.02% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
30%
Jae-Hyun Hong
3,416,081₩23.8b13.4%no data
4.74%
Avril Barnes
539,650₩3.8b0%no data
2.99%
Sung-So Hong
339,650₩2.4b-71.7%no data
1.15%
Seok-Yun Hong
131,024₩913.2m0%no data
1.01%
Dimensional Fund Advisors LP
114,601₩798.8m21.9%no data
0.95%
Mi-Keun Jung
108,000₩752.8m0%no data
0.63%
Seung-So Hong
72,000₩501.8m0%no data
0.46%
Seung-Tong Hong
52,800₩368.0m0%no data
0.058%
Shinil Pharmaceutical Co., Ltd Employee Stock Ownership Association
6,563₩45.7m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.